300255 常山药业
交易中 05-20 13:33:03
资讯
新帖
简况
常山药业（300255）5月17日主力资金净卖出2543.34万元
证券之星 · 05-17 15:26
常山药业（300255）5月17日主力资金净卖出2543.34万元
常山药业（300255）5月9日主力资金净卖出1089.58万元
证券之星 · 05-09
常山药业（300255）5月9日主力资金净卖出1089.58万元
常山药业（300255）4月30日主力资金净卖出8653.11万元
证券之星 · 04-30
常山药业（300255）4月30日主力资金净卖出8653.11万元
常山药业(300255.SZ)发布2023年度业绩，由盈转亏至12.4亿元
智通财经 · 04-28
常山药业(300255.SZ)发布2023年度业绩，由盈转亏至12.4亿元
图解常山药业年报：第四季度单季净利润同比减1611.43%
证券之星 · 04-28
图解常山药业年报：第四季度单季净利润同比减1611.43%
龙虎榜 | 消闲派近2000万打板常山药业，方新侠2700万助攻奥维通信
格隆汇 · 04-25
龙虎榜 | 消闲派近2000万打板常山药业，方新侠2700万助攻奥维通信
4月25日常山药业涨停分析：化学原料药，创新药，医药概念热股
证券之星 · 04-25
4月25日常山药业涨停分析：化学原料药，创新药，医药概念热股
常山药业（300255）4月25日主力资金净买入2.19亿元
证券之星 · 04-25
常山药业（300255）4月25日主力资金净买入2.19亿元
减肥药概念股震荡走高 常山药业20CM涨停
市场资讯 · 04-25
减肥药概念股震荡走高 常山药业20CM涨停
异动快报：常山药业（300255）4月25日9点31分触及涨停板
证券之星 · 04-25
异动快报：常山药业（300255）4月25日9点31分触及涨停板
【异动股】减肥药板块下挫，常山药业(300255.CN)跌3.49%
财华社 · 03-20
【异动股】减肥药板块下挫，常山药业(300255.CN)跌3.49%
美股减肥药巨头大涨刺激，A股概念股持续火爆，高盛也来点火...
格隆汇 · 03-08
美股减肥药巨头大涨刺激，A股概念股持续火爆，高盛也来点火...
常山药业控股股东拟转让近6%股权，牛散“杨明焕”欲斥资近5亿接手！
e公司 · 02-23
常山药业控股股东拟转让近6%股权，牛散“杨明焕”欲斥资近5亿接手！
常山药业(300255.SZ)实控人高树华拟协议转让5.77%股份
智通财经网 · 02-23
常山药业(300255.SZ)实控人高树华拟协议转让5.77%股份
常山药业(300255.SZ)：依诺肝素钠注射液获巴基斯坦药品注册证书
智通财经网 · 02-23
常山药业(300255.SZ)：依诺肝素钠注射液获巴基斯坦药品注册证书
10天狂揽29亿票房！热辣滚烫火出“贾玲概念股”，减肥药、健身概念齐上阵
格隆汇 · 02-19
10天狂揽29亿票房！热辣滚烫火出“贾玲概念股”，减肥药、健身概念齐上阵
常山药业(300255.SZ)发预亏，预计2023年度净亏损10亿元至12亿元 同比由盈转亏
智通财经网 · 01-30
常山药业(300255.SZ)发预亏，预计2023年度净亏损10亿元至12亿元 同比由盈转亏
概念掘金 | 国内首个！口服“减肥药”在华获批上市，哪些公司有望受益？
格隆汇 · 01-29
概念掘金 | 国内首个！口服“减肥药”在华获批上市，哪些公司有望受益？
智通A股龙虎榜统计|12月5日
智通财经网 · 2023-12-06
智通A股龙虎榜统计|12月5日
龙虎榜 | 香港东路爆砸“明星股”三伯硕，方新侠超6000万买入常山药业
格隆汇 · 2023-11-23
龙虎榜 | 香港东路爆砸“明星股”三伯硕，方新侠超6000万买入常山药业
公司概况
公司名称：
河北常山生化药业股份有限公司
所属行业：
医药制造业
上市日期：
2011-08-19
主营业务：
河北常山生化药业股份有限公司主营业务是研发、生产和销售治疗心脑血管疾病药物。公司主要产品有普通肝素原料药、低分子肝素原料药、低分子肝素制剂、普通肝素制剂。公司是国内少数拥有完整肝素产品产业链、能够同时从事肝素粗品、肝素原料药和肝素制剂药品研发、生产和销售的领军企业之一。
发行价格：
28.00
{"stockData":{"symbol":"300255","market":"SZ","secType":"STK","nameCN":"常山药业","latestPrice":11,"timestamp":1716183183000,"preClose":11.34,"halted":0,"volume":17312873,"delay":0,"floatShares":916000000,"shares":919000000,"eps":-1.4215,"marketStatus":"交易中","marketStatusCode":2,"change":-0.34,"latestTime":"05-20 13:33:03","open":11,"high":11.18,"low":10.91,"amount":191000000,"amplitude":0.0238,"askPrice":11.01,"askSize":158,"bidPrice":11,"bidSize":546,"shortable":0,"etf":0,"ttmEps":-1.4215,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1716188400000},"adr":0,"adjPreClose":11.34,"symbolType":"stock","openAndCloseTimeList":[[1716168600000,1716175800000],[1716181200000,1716188400000]],"highLimit":12.47,"lowLimit":10.21,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":919060878,"pbRate":5.96,"roa":"--","roe":"--","epsLYR":-1.35,"committee":0.470816,"marketValue":10110000000,"floatMarketCap":10074000000,"peRate":-7.738305,"changeRate":-0.03,"turnoverRate":0.0189,"status":1},"requestUrl":"/m/hq/s/300255/wiki","defaultTab":"wiki","newsList":[{"id":"2436649599","title":"常山药业（300255）5月17日主力资金净卖出2543.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2436649599","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2436649599?lang=zh_cn&edition=full","pubTime":"2024-05-17 15:26","pubTimestamp":1715930768,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月17日收盘，常山药业报收于11.34元，下跌1.82%，换手率2.21%，成交量20.2万手，成交额2.29亿元。常山药业主营业务：拥有完整肝素产品产业链、能够同时从事肝素粗品、肝素原料药和肝素制剂药品研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051700022158.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434052219","title":"常山药业（300255）5月9日主力资金净卖出1089.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434052219","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434052219?lang=zh_cn&edition=full","pubTime":"2024-05-09 15:26","pubTimestamp":1715239608,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月9日收盘，常山药业报收于11.86元，下跌0.92%，换手率2.9%，成交量26.55万手，成交额3.16亿元。常山药业主营业务：拥有完整肝素产品产业链、能够同时从事肝素粗品、肝素原料药和肝素制剂药品研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900022164.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431336666","title":"常山药业（300255）4月30日主力资金净卖出8653.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431336666","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431336666?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:27","pubTimestamp":1714462066,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月30日收盘，常山药业报收于11.67元，下跌4.19%，换手率4.99%，成交量45.69万手，成交额5.41亿元。常山药业主营业务：拥有完整肝素产品产业链、能够同时从事肝素粗品、肝素原料药和肝素制剂药品研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000026875.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430039403","title":"常山药业(300255.SZ)发布2023年度业绩，由盈转亏至12.4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430039403","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430039403?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:29","pubTimestamp":1714296558,"startTime":"0","endTime":"0","summary":"智通财经APP讯，常山药业(300255.SZ)发布2023年年度报告，该公司营业收入为14.1亿元，同比减少39.63%。归属于上市公司股东的净亏损为12.4亿元。归属于上市公司股东的扣除非经常性损益的净亏损为12.58亿元。基本每股亏损为1.35元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1113390.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430029033","title":"图解常山药业年报：第四季度单季净利润同比减1611.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430029033","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430029033?lang=zh_cn&edition=full","pubTime":"2024-04-28 16:54","pubTimestamp":1714294465,"startTime":"0","endTime":"0","summary":"证券之星消息，常山药业2023年年报显示，公司主营收入14.1亿元，同比下降39.63%；归母净利润-12.4亿元，同比下降7181.47%；扣非净利润-12.58亿元，同比下降14608.07%；其中2023年第四季度，公司单季度主营收入2.71亿元，同比下降50.07%；单季度归母净利润-8.52亿元，同比下降1611.43%；单季度扣非净利润-8.56亿元，同比下降1484.2%；负债率60.85%，投资收益0.7万元，财务费用9294.25万元，毛利率22.5%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800004274.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430474104","title":"龙虎榜 | 消闲派近2000万打板常山药业，方新侠2700万助攻奥维通信","url":"https://stock-news.laohu8.com/highlight/detail?id=2430474104","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2430474104?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:57","pubTimestamp":1714039079,"startTime":"0","endTime":"0","summary":"共有40只个股上榜，涉及机构专用席位的个股有20只","market":"hk","thumbnail":"https://img3.gelonghui.com/59c05-cdf9f55d-e978-435e-b568-08dc535163e7.jpg?guru_height=640&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/59c05-cdf9f55d-e978-435e-b568-08dc535163e7.jpg?guru_height=640&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/723949","is_publish_highlight":false,"gpt_icon":0},{"id":"2430421337","title":"4月25日常山药业涨停分析：化学原料药，创新药，医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430421337","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430421337?lang=zh_cn&edition=full","pubTime":"2024-04-25 15:28","pubTimestamp":1714030125,"startTime":"0","endTime":"0","summary":"证券之星消息，常山药业涨停收盘，收盘价11.77元。该股于9点31分涨停，未打开涨停，截止收盘封单资金为1.57亿元，占其流通市值1.45%。4月25日的资金流向数据方面，主力资金净流入2.19亿元，占总成交额41.29%，游资资金净流出1.31亿元，占总成交额24.68%，散户资金净流出8800.39万元，占总成交额16.61%。近5日资金流向一览见下表：该股为化学原料药，创新药，医药概念热股，当日化学原料药概念上涨2.05%，创新药概念上涨1.85%，医药概念上涨1.42%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500026171.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430429553","title":"常山药业（300255）4月25日主力资金净买入2.19亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430429553","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430429553?lang=zh_cn&edition=full","pubTime":"2024-04-25 15:18","pubTimestamp":1714029520,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月25日收盘，常山药业报收于11.77元，上涨19.98%，涨停，换手率4.94%，成交量45.22万手，成交额5.3亿元。常山药业主营业务：拥有完整肝素产品产业链、能够同时从事肝素粗品、肝素原料药和肝素制剂药品研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500025734.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430414615","title":"减肥药概念股震荡走高 常山药业20CM涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2430414615","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2430414615?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:38","pubTimestamp":1714009080,"startTime":"0","endTime":"0","summary":"专题：A股震荡上扬 机构预计未来股指仍维持震荡格局\n 4月25日消息，常山药业20CM涨停，百花医药（维权）、博济医药涨超5%，翰宇药业、华森制药、双鹭药业、华东医药等跟涨。\n 消息面上，常山药业昨日公告称，由控股子公司常山凯捷健生物药物研发（河北）有限公司开发的艾本那肽注射液（GLP-1受体激动剂）首个新药上市申请（NDA）已获国家药品监督管理局（NMPA）受理，申报的适应症为用于治疗2型糖尿病。。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：王其霖","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/2024-04-25/doc-inaszaue6217951.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/2024-04-25/doc-inaszaue6217951.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430441126","title":"异动快报：常山药业（300255）4月25日9点31分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2430441126","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430441126?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:35","pubTimestamp":1714008957,"startTime":"0","endTime":"0","summary":"证券之星4月25日盘中消息，9点31分常山药业触及涨停板。目前价格11.77，上涨19.98%。其所属行业化学制药目前上涨。领涨股为新天地。该股为创新药，化学原料药，医药概念热股，当日创新药概念上涨1.62%，化学原料药概念上涨1.61%，医药概念上涨1.15%。4月24日的资金流向数据方面，主力资金净流出434.38万元，占总成交额1.93%，游资资金净流出270.37万元，占总成交额1.2%，散户资金净流入704.75万元，占总成交额3.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500019075.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2420585677","title":"【异动股】减肥药板块下挫，常山药业(300255.CN)跌3.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420585677","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2420585677?lang=zh_cn&edition=full","pubTime":"2024-03-20 09:45","pubTimestamp":1710899120,"startTime":"0","endTime":"0","summary":"今日早盘，截至09:45，减肥药板块下挫。常山药业(300255.CN)跌3.49%报12.45元，爱美客(300896.CN)跌3.02%报342.24元，翰宇药业(300199.CN)跌2.91%报13.03元，博济医药(300404.CN)跌1.81%报8.13元，睿智医药(300149.CN)跌1.48%报5.99元，金凯生科(301509.CN)跌1.41%报63.56元，普利制药(300630.CN)跌1.34%报19.85元，通化东宝(600867.CN)跌1.25%报10.26元。","market":"other","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/65fa3fb09dfc4250c48f417d","is_publish_highlight":false,"gpt_icon":0},{"id":"2417776067","title":"美股减肥药巨头大涨刺激，A股概念股持续火爆，高盛也来点火...","url":"https://stock-news.laohu8.com/highlight/detail?id=2417776067","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2417776067?lang=zh_cn&edition=full","pubTime":"2024-03-08 11:12","pubTimestamp":1709867558,"startTime":"0","endTime":"0","summary":"供不应求","market":"us","thumbnail":"https://img3.gelonghui.com/30512-ae89b02e-0177-4110-95da-fc4ee514fc80.jpg?guru_height=370&guru_width=660","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/30512-ae89b02e-0177-4110-95da-fc4ee514fc80.jpg?guru_height=370&guru_width=660"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/703805","is_publish_highlight":false,"gpt_icon":0},{"id":"2413091765","title":"常山药业控股股东拟转让近6%股权，牛散“杨明焕”欲斥资近5亿接手！","url":"https://stock-news.laohu8.com/highlight/detail?id=2413091765","media":"e公司","top":-1,"share":"https://www.laohu8.com/m/news/2413091765?lang=zh_cn&edition=full","pubTime":"2024-02-23 21:21","pubTimestamp":1708694460,"startTime":"0","endTime":"0","summary":" 2月23日午间，常山药业发布公告，收到控股股东、实际控制人高树华通知，因自身资金需求，高树华拟协议转让近6%的股份。 公告显示，高树华目前持有持有常山药业3.34亿股，占该上市公司总股本比例为36.30%。常山药业表示，该价格系根据本协议签署之日前一交易日转让股份二级 市场收盘价为定价基准，比照大宗交易的规定的转让价格标准确定。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-02-23/doc-inaiztcf5212792.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-02-23/doc-inaiztcf5212792.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2413739433","title":"常山药业(300255.SZ)实控人高树华拟协议转让5.77%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2413739433","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2413739433?lang=zh_cn&edition=full","pubTime":"2024-02-23 16:17","pubTimestamp":1708676220,"startTime":"0","endTime":"0","summary":"常山药业(300255.SZ)公告，公司控股股东、实际控制人高树华拟通过协议转让方式将其持有公司5300万股无限售流通股(占公司总股本比例5.77%)转让给自然人杨明焕。标的股份转让价格合计金额为4.88亿元。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-23/doc-inaizhpi0829207.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-23/doc-inaizhpi0829207.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2413673531","title":"常山药业(300255.SZ)：依诺肝素钠注射液获巴基斯坦药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2413673531","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2413673531?lang=zh_cn&edition=full","pubTime":"2024-02-23 15:49","pubTimestamp":1708674540,"startTime":"0","endTime":"0","summary":"常山药业(300255.SZ)公告，公司药品依诺肝素钠注射液获得巴基斯坦药品监督管理局签发的药品注册证书。依诺肝素钠注射液用于预防静脉血栓栓塞性疾病(预防静脉内血栓形成)，特别是与骨科或普外手术有关的血栓形成;治疗已形成的深静脉栓塞，伴或不伴有肺栓塞，临床症状不严重，不包括需要外科手术或溶栓剂治疗的肺栓塞;与阿司匹林合用，治疗不稳定性心绞痛及非Q波心肌梗死;用于血液透析体外循环中，防止血栓形成。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-23/doc-inaizhpm5377229.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-23/doc-inaizhpm5377229.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2412490529","title":"10天狂揽29亿票房！热辣滚烫火出“贾玲概念股”，减肥药、健身概念齐上阵","url":"https://stock-news.laohu8.com/highlight/detail?id=2412490529","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2412490529?lang=zh_cn&edition=full","pubTime":"2024-02-19 15:52","pubTimestamp":1708329177,"startTime":"0","endTime":"0","summary":" 新年的第一份热血来自贾玲！","market":"hk","thumbnail":"https://img3.gelonghui.com/1e89b-c9590e1b-acd8-44e7-8cd5-9e4aa09f0411.jpg?guru_height=808&guru_width=1620","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/1e89b-c9590e1b-acd8-44e7-8cd5-9e4aa09f0411.jpg?guru_height=808&guru_width=1620"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/694229","is_publish_highlight":false,"gpt_icon":0},{"id":"2407493369","title":"常山药业(300255.SZ)发预亏，预计2023年度净亏损10亿元至12亿元 同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2407493369","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2407493369?lang=zh_cn&edition=full","pubTime":"2024-01-30 23:43","pubTimestamp":1706629380,"startTime":"0","endTime":"0","summary":"常山药业发布2023年度业绩预亏公告，预计全年归属于上市公司股东净亏损10亿元至12亿元，同比由盈转亏。2023年营业收入中，约60%来源于国内肝素制剂产品销售。同时，由于药品集中带量采购政策的影响，国内低分子肝素制剂的市场占有率结构发生变化，2023年度，公司主力品种低分子量肝素钙注射液销量大幅下降，导致公司收入和净利润下降。股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-30/doc-inafiqsx9803750.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-30/doc-inafiqsx9803750.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2407006653","title":"概念掘金 | 国内首个！口服“减肥药”在华获批上市，哪些公司有望受益？","url":"https://stock-news.laohu8.com/highlight/detail?id=2407006653","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2407006653?lang=zh_cn&edition=full","pubTime":"2024-01-29 10:21","pubTimestamp":1706494903,"startTime":"0","endTime":"0","summary":"中国GLP-1减重市场有望突破千亿","market":"us","thumbnail":"https://img3.gelonghui.com/cde03-d1a76e07-baae-4601-a193-b8aac34cc6d5.jpg?guru_height=852&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/cde03-d1a76e07-baae-4601-a193-b8aac34cc6d5.jpg?guru_height=852&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/689324","is_publish_highlight":false,"gpt_icon":0},{"id":"2389771927","title":"智通A股龙虎榜统计|12月5日","url":"https://stock-news.laohu8.com/highlight/detail?id=2389771927","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2389771927?lang=zh_cn&edition=full","pubTime":"2023-12-06 07:01","pubTimestamp":1701817260,"startTime":"0","endTime":"0","summary":"12月5日共有46家公司现身A股龙虎榜。其中，通化金马、西藏矿业、常山药业龙虎榜前5大席位合计净买入金额排名前三，分别是3.67亿元、3.3亿元、1.08亿元。股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-06/doc-imzwzpka6144526.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-06/doc-imzwzpka6144526.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2385647682","title":"龙虎榜 | 香港东路爆砸“明星股”三伯硕，方新侠超6000万买入常山药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2385647682","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2385647682?lang=zh_cn&edition=full","pubTime":"2023-11-23 17:59","pubTimestamp":1700733597,"startTime":"0","endTime":"0","summary":"共有44只个股上榜，涉及机构专用席位的个股有20只","market":"hk","thumbnail":"https://img3.gelonghui.com/59c05-c92d9b91-be00-4629-a831-a00763ac2472.jpg","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/59c05-c92d9b91-be00-4629-a831-a00763ac2472.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/667255","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-08-19","address":"河北省石家庄市正定县中国(河北)自由贸易试验区正定片区高新技术产业开发区南区梦龙街71号","stockEarnings":[{"period":"1week","weight":-0.0131},{"period":"1month","weight":0.1583},{"period":"3month","weight":0.3049},{"period":"6month","weight":-0.0526},{"period":"1year","weight":1.2886},{"period":"ytd","weight":-0.1284}],"companyName":"河北常山生化药业股份有限公司","boardCode":"AI0027","perCapita":"15624股","boardName":"医药制造业","registeredCapital":"91906万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":" 河北常山生化药业股份有限公司主营业务是研发、生产和销售治疗心脑血管疾病药物。公司主要产品有普通肝素原料药、低分子肝素原料药、低分子肝素制剂、普通肝素制剂。公司是国内少数拥有完整肝素产品产业链、能够同时从事肝素粗品、肝素原料药和肝素制剂药品研发、生产和销售的领军企业之一。","serverTime":1716183186009,"listedPrice":28,"stockholders":"58615人(较上一季度减少9.32%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供常山药业(300255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"常山药业,300255,常山药业股票,常山药业股票老虎,常山药业股票老虎国际,常山药业行情,常山药业股票行情,常山药业股价,常山药业股市,常山药业股票价格,常山药业股票交易,常山药业股票购买,常山药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供常山药业(300255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}